DEA - Supreme Court Ruling Will Help This Company's Battle Against DEA's 'Kangaroo Court' And Anti-Cannabis Research Policy | Benzinga
The Supreme Court recently ruled in a case Jarkesy versus Securities and Exchange Commission (SEC) that defendants have a right to a jury trial under the Seventh Amendment when facing enforcement actions from federal agencies, writes Vox.
While this case considered a hedge fund manager accused of defrauding investors and his right to a jury trial to determine if he violated federal securities law or if the government acted properly when it tried him before an official known as an "administrative law judge," (ALJ) the ruling will impact similar cases.
Last August, MMJ filed a petition for a writ of mandamus in the U.S. Court of Appeals for the District of Columbia Circuit over a bulk manufacturing application submitted almost six years ago and never processed. MMJ’s president and founder Duane Boise previously told Benzinga that the inaction goes directly against the Control Substance Act, negatively impacts MMJ and ignores its effort to help those suffering individuals from Huntington’s Disease and Multiple Sclerosis through clinical research.
Upon discovering that DEA director Anne Milgram “illegally appointed the administrative law Judge Teresa Wallbaum” to hear the case, Megan Sheehan and Associates, lawyers representing MMJ, filed for relief seeking an ...